Williams Thomas N, Mwangi Tabitha W, Roberts David J, Alexander Neal D, Weatherall David J, Wambua Sammy, Kortok Moses, Snow Robert W, Marsh Kevin
Kenya Medical Research Institute, Wellcome Trust Programme, Centre for Geographic Medicine Research, Coast, Kilifi District Hospital, Kilifi, Kenya.
PLoS Med. 2005 May;2(5):e128. doi: 10.1371/journal.pmed.0020128. Epub 2005 May 31.
Malaria resistance by the sickle cell trait (genotype HbAS) has served as the prime example of genetic selection for over half a century. Nevertheless, the mechanism of this resistance remains the subject of considerable debate. While it probably involves innate factors such as the reduced ability of Plasmodium falciparum parasites to grow and multiply in HbAS erythrocytes, recent observations suggest that it might also involve the accelerated acquisition of malaria-specific immunity.
We studied the age-specific protection afforded by HbAS against clinical malaria in children living on the coast of Kenya. We found that protection increased with age from only 20% in the first 2 y of life to a maximum of 56% by the age of 10 y, returning thereafter to 30% in participants greater than 10 y old.
Our observations suggest that malaria protection by HbAS involves the enhancement of not only innate but also of acquired immunity to the parasite. A better understanding of the underlying mechanisms might yield important insights into both these processes.
半个多世纪以来,镰状细胞性状(基因型HbAS)导致的疟疾抗性一直是基因选择的主要例证。然而,这种抗性的机制仍然是相当多争论的主题。虽然它可能涉及先天因素,如恶性疟原虫在HbAS红细胞中生长和繁殖能力的降低,但最近的观察表明,它也可能涉及疟疾特异性免疫力的加速获得。
我们研究了HbAS对肯尼亚沿海地区儿童临床疟疾的年龄特异性保护作用。我们发现,保护作用随年龄增长而增加,从生命最初2年的仅20%增加到10岁时的最高56%,此后在10岁以上的参与者中降至30%。
我们的观察结果表明,HbAS对疟疾的保护作用不仅涉及对寄生虫先天免疫力的增强,还涉及后天免疫力的增强。更好地理解潜在机制可能会对这两个过程产生重要的见解。